Neuroprotective Effect of Ramipril Is Mediated by AT2 in a Mouse MODEL of Paclitaxel-Induced Peripheral Neuropathy

Paclitaxel (PTX)-induced peripheral neuropathy (PIPN) induces numerous symptoms affecting patient quality of life, leading to decreased doses or even to cessation of anticancer therapy. Previous studies have reported that a widely used drug, ramipril, improves neuroprotection in several rodent model...

Full description

Bibliographic Details
Main Authors: Hichem Bouchenaki, Amandine Bernard, Flavien Bessaguet, Simon Frachet, Laurence Richard, Franck Sturtz, Laurent Magy, Sylvie Bourthoumieu, Claire Demiot, Aurore Danigo
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/14/4/848
_version_ 1797434321712185344
author Hichem Bouchenaki
Amandine Bernard
Flavien Bessaguet
Simon Frachet
Laurence Richard
Franck Sturtz
Laurent Magy
Sylvie Bourthoumieu
Claire Demiot
Aurore Danigo
author_facet Hichem Bouchenaki
Amandine Bernard
Flavien Bessaguet
Simon Frachet
Laurence Richard
Franck Sturtz
Laurent Magy
Sylvie Bourthoumieu
Claire Demiot
Aurore Danigo
author_sort Hichem Bouchenaki
collection DOAJ
description Paclitaxel (PTX)-induced peripheral neuropathy (PIPN) induces numerous symptoms affecting patient quality of life, leading to decreased doses or even to cessation of anticancer therapy. Previous studies have reported that a widely used drug, ramipril, improves neuroprotection in several rodent models of peripheral neuropathy. The protective role of the angiotensin II type 2 receptor (AT2) in the central and peripheral nervous systems is well-established. Here, we evaluate the effects of ramipril in the prevention of PIPN and the involvement of AT2 in this effect. Paclitaxel was administered in wild type or AT2-deficient mice on alternate days for 8 days, at a cumulative dose of 8 mg/kg (2 mg/kg per injection). Ramipril, PD123319 (an AT2 antagonist), or a combination of both were administered one day before PTX administration, and daily for the next twenty days. PTX-administered mice developed mechanical allodynia and showed a loss of sensory nerve fibers. Ramipril prevented the functional and morphological alterations in PTX mice. The preventive effect of ramipril against tactile allodynia was completely absent in AT2-deficient mice and was counteracted by PD123319 administration in wild type mice. Our work highlights the potential of ramipril as a novel preventive treatment for PIPN, and points to the involvement of AT2 in the neuroprotective role of ramipril in PIPN.
first_indexed 2024-03-09T10:30:32Z
format Article
id doaj.art-da4dfbc37d634bef9db9c80ed1dbc4ea
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-03-09T10:30:32Z
publishDate 2022-04-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-da4dfbc37d634bef9db9c80ed1dbc4ea2023-12-01T21:19:00ZengMDPI AGPharmaceutics1999-49232022-04-0114484810.3390/pharmaceutics14040848Neuroprotective Effect of Ramipril Is Mediated by AT2 in a Mouse MODEL of Paclitaxel-Induced Peripheral NeuropathyHichem Bouchenaki0Amandine Bernard1Flavien Bessaguet2Simon Frachet3Laurence Richard4Franck Sturtz5Laurent Magy6Sylvie Bourthoumieu7Claire Demiot8Aurore Danigo9UR 20218-NeurIT, Faculties of Medicine and Pharmacy, University of Limoges, 87025 Limoges, FranceUR 20218-NeurIT, Faculties of Medicine and Pharmacy, University of Limoges, 87025 Limoges, FranceINSERM 1083 CNRS UMR 6015 Mitovasc Laboratory, CarMe Team, University of Angers, 49045 Angers, FranceUR 20218-NeurIT, Faculties of Medicine and Pharmacy, University of Limoges, 87025 Limoges, FranceUR 20218-NeurIT, Faculties of Medicine and Pharmacy, University of Limoges, 87025 Limoges, FranceUR 20218-NeurIT, Faculties of Medicine and Pharmacy, University of Limoges, 87025 Limoges, FranceUR 20218-NeurIT, Faculties of Medicine and Pharmacy, University of Limoges, 87025 Limoges, FranceUR 20218-NeurIT, Faculties of Medicine and Pharmacy, University of Limoges, 87025 Limoges, FranceUR 20218-NeurIT, Faculties of Medicine and Pharmacy, University of Limoges, 87025 Limoges, FranceUR 20218-NeurIT, Faculties of Medicine and Pharmacy, University of Limoges, 87025 Limoges, FrancePaclitaxel (PTX)-induced peripheral neuropathy (PIPN) induces numerous symptoms affecting patient quality of life, leading to decreased doses or even to cessation of anticancer therapy. Previous studies have reported that a widely used drug, ramipril, improves neuroprotection in several rodent models of peripheral neuropathy. The protective role of the angiotensin II type 2 receptor (AT2) in the central and peripheral nervous systems is well-established. Here, we evaluate the effects of ramipril in the prevention of PIPN and the involvement of AT2 in this effect. Paclitaxel was administered in wild type or AT2-deficient mice on alternate days for 8 days, at a cumulative dose of 8 mg/kg (2 mg/kg per injection). Ramipril, PD123319 (an AT2 antagonist), or a combination of both were administered one day before PTX administration, and daily for the next twenty days. PTX-administered mice developed mechanical allodynia and showed a loss of sensory nerve fibers. Ramipril prevented the functional and morphological alterations in PTX mice. The preventive effect of ramipril against tactile allodynia was completely absent in AT2-deficient mice and was counteracted by PD123319 administration in wild type mice. Our work highlights the potential of ramipril as a novel preventive treatment for PIPN, and points to the involvement of AT2 in the neuroprotective role of ramipril in PIPN.https://www.mdpi.com/1999-4923/14/4/848paclitaxel-induced peripheral neuropathyangiotensin converting enzyme inhibitorRamiprilneuropathic painmouse model
spellingShingle Hichem Bouchenaki
Amandine Bernard
Flavien Bessaguet
Simon Frachet
Laurence Richard
Franck Sturtz
Laurent Magy
Sylvie Bourthoumieu
Claire Demiot
Aurore Danigo
Neuroprotective Effect of Ramipril Is Mediated by AT2 in a Mouse MODEL of Paclitaxel-Induced Peripheral Neuropathy
Pharmaceutics
paclitaxel-induced peripheral neuropathy
angiotensin converting enzyme inhibitor
Ramipril
neuropathic pain
mouse model
title Neuroprotective Effect of Ramipril Is Mediated by AT2 in a Mouse MODEL of Paclitaxel-Induced Peripheral Neuropathy
title_full Neuroprotective Effect of Ramipril Is Mediated by AT2 in a Mouse MODEL of Paclitaxel-Induced Peripheral Neuropathy
title_fullStr Neuroprotective Effect of Ramipril Is Mediated by AT2 in a Mouse MODEL of Paclitaxel-Induced Peripheral Neuropathy
title_full_unstemmed Neuroprotective Effect of Ramipril Is Mediated by AT2 in a Mouse MODEL of Paclitaxel-Induced Peripheral Neuropathy
title_short Neuroprotective Effect of Ramipril Is Mediated by AT2 in a Mouse MODEL of Paclitaxel-Induced Peripheral Neuropathy
title_sort neuroprotective effect of ramipril is mediated by at2 in a mouse model of paclitaxel induced peripheral neuropathy
topic paclitaxel-induced peripheral neuropathy
angiotensin converting enzyme inhibitor
Ramipril
neuropathic pain
mouse model
url https://www.mdpi.com/1999-4923/14/4/848
work_keys_str_mv AT hichembouchenaki neuroprotectiveeffectoframiprilismediatedbyat2inamousemodelofpaclitaxelinducedperipheralneuropathy
AT amandinebernard neuroprotectiveeffectoframiprilismediatedbyat2inamousemodelofpaclitaxelinducedperipheralneuropathy
AT flavienbessaguet neuroprotectiveeffectoframiprilismediatedbyat2inamousemodelofpaclitaxelinducedperipheralneuropathy
AT simonfrachet neuroprotectiveeffectoframiprilismediatedbyat2inamousemodelofpaclitaxelinducedperipheralneuropathy
AT laurencerichard neuroprotectiveeffectoframiprilismediatedbyat2inamousemodelofpaclitaxelinducedperipheralneuropathy
AT francksturtz neuroprotectiveeffectoframiprilismediatedbyat2inamousemodelofpaclitaxelinducedperipheralneuropathy
AT laurentmagy neuroprotectiveeffectoframiprilismediatedbyat2inamousemodelofpaclitaxelinducedperipheralneuropathy
AT sylviebourthoumieu neuroprotectiveeffectoframiprilismediatedbyat2inamousemodelofpaclitaxelinducedperipheralneuropathy
AT clairedemiot neuroprotectiveeffectoframiprilismediatedbyat2inamousemodelofpaclitaxelinducedperipheralneuropathy
AT auroredanigo neuroprotectiveeffectoframiprilismediatedbyat2inamousemodelofpaclitaxelinducedperipheralneuropathy